These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 37506283)
1. Disrupting Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Latent Replication with a Small Molecule Inhibitor. Berwanger A; Stein SC; Kany AM; Gartner M; Loretz B; Lehr CM; Hirsch AKH; Schulz TF; Empting M J Med Chem; 2023 Aug; 66(15):10782-10790. PubMed ID: 37506283 [TBL] [Abstract][Full Text] [Related]
2. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication. Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712 [TBL] [Abstract][Full Text] [Related]
3. Hit-to-lead optimization of a latency-associated nuclear antigen inhibitor against Kaposi's sarcoma-associated herpesvirus infections. Kirsch P; Stein SC; Berwanger A; Rinkes J; Jakob V; Schulz TF; Empting M Eur J Med Chem; 2020 Sep; 202():112525. PubMed ID: 32634628 [TBL] [Abstract][Full Text] [Related]
4. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. Hu J; Garber AC; Renne R J Virol; 2002 Nov; 76(22):11677-87. PubMed ID: 12388727 [TBL] [Abstract][Full Text] [Related]
5. Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis. Sun Z; Jha HC; Robertson ES J Virol; 2015 Oct; 89(20):10206-18. PubMed ID: 26223641 [TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin. Lu J; Jha HC; Verma SC; Sun Z; Banerjee S; Dzeng R; Robertson ES J Virol; 2014 Apr; 88(8):4204-17. PubMed ID: 24478433 [TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats. Purushothaman P; McDowell ME; McGuinness J; Salas R; Rumjahn SM; Verma SC J Virol; 2012 Sep; 86(18):9983-94. PubMed ID: 22761383 [TBL] [Abstract][Full Text] [Related]
8. Assay Development and High-Throughput Screening for Inhibitors of Kaposi's Sarcoma-Associated Herpesvirus N-Terminal Latency-Associated Nuclear Antigen Binding to Nucleosomes. Beauchemin C; Moerke NJ; Faloon P; Kaye KM J Biomol Screen; 2014 Jul; 19(6):947-58. PubMed ID: 24518064 [TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. Lan K; Kuppers DA; Verma SC; Robertson ES J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750 [TBL] [Abstract][Full Text] [Related]
10. Kaposi's Sarcoma-Associated Herpesvirus LANA-Adjacent Regions with Distinct Functions in Episome Segregation or Maintenance. Juillard F; De León Vázquez E; Tan M; Li S; Kaye KM J Virol; 2019 Mar; 93(6):. PubMed ID: 30626680 [TBL] [Abstract][Full Text] [Related]
11. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications. Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ mBio; 2018 May; 9(3):. PubMed ID: 29739902 [TBL] [Abstract][Full Text] [Related]
12. Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance. Skalsky RL; Hu J; Renne R J Virol; 2007 Sep; 81(18):9825-37. PubMed ID: 17626102 [TBL] [Abstract][Full Text] [Related]
13. NDRG1 facilitates the replication and persistence of Kaposi's sarcoma-associated herpesvirus by interacting with the DNA polymerase clamp PCNA. Zhang F; Liang D; Lin X; Zou Z; Sun R; Wang X; Liang X; Kaye KM; Lan K PLoS Pathog; 2019 Feb; 15(2):e1007628. PubMed ID: 30811506 [TBL] [Abstract][Full Text] [Related]
14. Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma. Staudt MR; Dittmer DP Curr Drug Targets Infect Disord; 2003 Jun; 3(2):129-35. PubMed ID: 12769790 [TBL] [Abstract][Full Text] [Related]
15. The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA. Jäger W; Santag S; Weidner-Glunde M; Gellermann E; Kati S; Pietrek M; Viejo-Borbolla A; Schulz TF J Virol; 2012 Jun; 86(12):6745-57. PubMed ID: 22514345 [TBL] [Abstract][Full Text] [Related]